DFX Intelligence
Venture Capital Intelligence
Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.
Companies / Castle Creek Biosciences, Inc.
Castle Creek Biosciences, Inc.
Facts
- Year of incorporation
- unknown
- Revenue range (Form D)
- Decline to Disclosesec.gov
- Rounds on record
- 1
- Disclosed raised
- unknownsum of rounds with a disclosed amount only
- Named investors
- 1
Financing history
1 rounds
- Feb 24, 2025Form D equity offering · $75.0M (form d sold) · 30 investorsFact SEC EDGAR Form D data sets (quarterly) · “Castle Creek Biosciences, Inc. filed Form D: $75,000,000 sold of $75,000,000, Biotechnology”
Investors on record
1 edges
- Valor Equity Partners portfolio listing Fact valorep.com
People
3 officers, 5 directors
- Darien Parhad Executive Officer sec.gov
- Jude Sullivan Executive Officer sec.gov
- Matthew Gantz Executive Officer/Director sec.gov
- Matthew Crabtree Director Fact
- Jeffrey Aronin Director Fact
- Patrick Morris Director Fact
- Antonio Gracias Director Fact
- David Brill Director Fact
Timeline
1
- Feb 25, 2025Castle Creek Biosciences, Inc. filed Form D: $75,000,000 sold of $75,000,000, BiotechnologyForm D filed Fact SEC EDGAR Form D data sets (quarterly)
Evidence
16 observations
Every observation on this company
- Entity type: Corporation Feb 25, 2025 Fact SEC EDGAR Form D data sets (quarterly)
- Form D industry group: Biotechnology Feb 25, 2025 Fact SEC EDGAR Form D data sets (quarterly)
- Amendment: false Feb 25, 2025 Fact SEC EDGAR Form D data sets (quarterly)
- Revenue range (Form D): Decline to Disclose Feb 25, 2025 Fact SEC EDGAR Form D data sets (quarterly)
- Incorporated: overFiveYears Feb 25, 2025 Fact SEC EDGAR Form D data sets (quarterly)
- Jurisdiction: DELAWARE Feb 25, 2025 Fact SEC EDGAR Form D data sets (quarterly)
- Amount sold (Form D): $75.0M Feb 25, 2025 Fact SEC EDGAR Form D data sets (quarterly)
- Offering amount (Form D): $75.0M Feb 25, 2025 Fact SEC EDGAR Form D data sets (quarterly)
- Exemptions: 06b Feb 25, 2025 Fact SEC EDGAR Form D data sets (quarterly)
- First sale: 2025-02-24 Feb 25, 2025 Fact SEC EDGAR Form D data sets (quarterly)
- Investors (Form D): 30 Feb 25, 2025 Fact SEC EDGAR Form D data sets (quarterly)
- Minimum investment (Form D): 0 Feb 25, 2025 Fact SEC EDGAR Form D data sets (quarterly)
- Securities offered: option Feb 25, 2025 Fact SEC EDGAR Form D data sets (quarterly)
- Office address: 405 Eagleview Boulevard, Exton, PA, 19341 Feb 25, 2025 Fact SEC EDGAR Form D data sets (quarterly)
- Listed on portfolio page: Valor Equity Partners Sep 16, 2026 Fact Venture organization websites (about, team, portfolio, thesis, news pages)
- Listed on portfolio page: Valor Equity Partners Sep 12, 2026 Fact Venture organization websites (about, team, portfolio, thesis, news pages)